ATP7B 抗体
(ATPase, Cu++ Transporting, beta Polypeptide (ATP7B))
This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein functions as a monomer, exporting copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease (WD). [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| ATP7B 抗体 (AA 1055-1354) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (Cy7) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 1351-1465) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 59-426) | 人 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 | Cow | 小鼠 Monoclonal |
|
|
|
| ATP7B 抗体 (AA 130-210) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| ATP7B 抗体 (AA 201-250) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant ATP7B 抗体 | 人 | 兔 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1055-1354
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 1351-1465
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 59-426
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 130-210
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 201-250
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 36D1236D12
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Latest Publications for our ATP7B 抗体
: "PAMAM dendrimer grafted cellulose paper scaffolds as a novel in vitro 3D liver model for drug screening applications." in: Colloids and surfaces. B, Biointerfaces, Vol. 172, pp. 346-354, (2019) (PubMed).
: "The release and detection of copper ions from ultrasmall theranostic Cu2-xSe nanoparticles." in: Nanoscale, Vol. 11, Issue 24, pp. 11819-11829, (2019) (PubMed).
: "Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma." in: Frontiers in oncology, Vol. 9, pp. 958, (2019) (PubMed).
: "The loss of copper is associated with the increase in copper metabolism MURR domain 1 in ischemic hearts of mice." in: Experimental biology and medicine (Maywood, N.J.), Vol. 243, Issue 9, pp. 780-785, (2018) (PubMed).
: "A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals." in: Journal of the American Chemical Society, (2018) (PubMed).
: "miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression." in: International journal of molecular medicine, Vol. 37, Issue 6, pp. 1636-42, (2016) (PubMed).
: "A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin." in: Pathology oncology research : POR, Vol. 21, Issue 2, pp. 389-97, (2015) (PubMed).
: "Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo." in: Biochemical pharmacology, Vol. 95, Issue 1, pp. 28-37, (2015) (PubMed).
: "Novel ATPase Cu(2+) transporting beta polypeptide mutations in Chinese families with Wilson's disease." in: PLoS ONE, Vol. 8, Issue 7, pp. e66526, (2013) (PubMed).
: "Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?" in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 23, Issue 1, pp. 60-4, (2012) (PubMed).
: "The release and detection of copper ions from ultrasmall theranostic Cu2-xSe nanoparticles." in: Nanoscale, Vol. 11, Issue 24, pp. 11819-11829, (2019) (PubMed).
: "Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma." in: Frontiers in oncology, Vol. 9, pp. 958, (2019) (PubMed).
: "The loss of copper is associated with the increase in copper metabolism MURR domain 1 in ischemic hearts of mice." in: Experimental biology and medicine (Maywood, N.J.), Vol. 243, Issue 9, pp. 780-785, (2018) (PubMed).
: "A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals." in: Journal of the American Chemical Society, (2018) (PubMed).
: "miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression." in: International journal of molecular medicine, Vol. 37, Issue 6, pp. 1636-42, (2016) (PubMed).
: "A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin." in: Pathology oncology research : POR, Vol. 21, Issue 2, pp. 389-97, (2015) (PubMed).
: "Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo." in: Biochemical pharmacology, Vol. 95, Issue 1, pp. 28-37, (2015) (PubMed).
: "Novel ATPase Cu(2+) transporting beta polypeptide mutations in Chinese families with Wilson's disease." in: PLoS ONE, Vol. 8, Issue 7, pp. e66526, (2013) (PubMed).
: "Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?" in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 23, Issue 1, pp. 60-4, (2012) (PubMed).
Aliases for ATP7B 抗体
ATPase copper transporting beta (ATP7B) 抗体ATPase, Cu++ transporting, beta polypeptide (Atp7b) 抗体
ATPase copper transporting beta (Atp7b) 抗体
ATPase, Cu++ transporting, beta polypeptide (Wilson disease) (atp7b) 抗体
copper-transporting ATPase 2 (LOC592143) 抗体
ATPase, Cu++ transporting, beta polypeptide (atp7b) 抗体
ATPase copper transporting beta (atp7b) 抗体
Atp7a 抗体
ATP7B 抗体
Hts 抗体
PINA 抗体
PWD 抗体
tx 抗体
WC1 抗体
WD 抗体
Wd 抗体
WND 抗体
您还需要查找其他产品吗？
- ATP7A 抗体
- ATP6V1H 抗体
- ATP6V1G3i 抗体
- ATP6V1G2 抗体
- ATP6V1F 抗体
- ATP6V1E2 抗体
- ATP6V1E1 抗体
- ATP6V1D 抗体
- ATP6V1C2 抗体
- ATP6V1C1 抗体
- ATP6V1B2 抗体
- ATP6V1B1 抗体
- ATP6V1A 抗体
- ATP6V0E2 抗体
- ATP6V0D2 抗体
- ATP6V0D1 抗体
- ATP6V0B 抗体
- ATP6V0A4 抗体
- ATP6V0A2 抗体
- ATP6AP2 抗体
- ATP8A1 抗体
- ATP8A2 抗体
- ATP8B1 抗体
- ATP8B3 抗体
- ATP8B4 抗体
- ATP9A 抗体
- ATPAF1 抗体
- ATPAF2 抗体
- ATPase 抗体
- ATPase Family, AAA Domain Containing 5 抗体
- ATPase Inhibitory Factor 1 抗体
- ATPase, Aminophospholipid Transporter, Class I, Type 8B, Member 2 抗体
- ATPase, H+ Transporting, Lysosomal 13kDa, V1 Subunit G1 抗体
- ATPase, H+ Transporting, Lysosomal 16kDa, V0 Subunit C 抗体
- ATPase, H+ Transporting, Lysosomal V0 Subunit A1 抗体
- ATPase, Na+/K+ Transporting, alpha 3 Polypeptide 抗体
- ATPase, Na+/K+ Transporting, beta 3 Polypeptide 抗体
- ATPBD3 抗体
- ATPBD4 抗体
- ATPOT1B 抗体
You are here:
